Agenus Inc reports results for the quarter ended in March - Earnings Summary

Agenus

07/05/2024 14:53

* Agenus Inc  AGEN.OQ  reported a quarterly adjusted loss of
$3.04​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-4.40.  The mean expectation of five analysts for the quarter
was for a loss of $3.22 per share. Wall Street expected
results to range from $-4.20 to $-1.75 per share.
    * Revenue rose 22.3% to $28.01 million from a year ago;
analysts
expected $40.70 million. 
    * Agenus Inc's reported EPS for the quarter was a loss of
$3.04​.
    * The company reported a quarterly loss of $63.45 million.
    * Agenus Inc shares had risen by 11.6% this quarter and
lost 21.8%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Agenus Inc is
$51.00 
This summary was machine generated from LSEG data May 7 at 01:52
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -3.22          -3.04          Beat
 Dec. 31 2023      -1.05          -2.60          Missed
 Sep. 30 2023      -3.84          -3.20          Beat
 Jun. 30 2023      -3.97          -4.00          Missed